Quark Pharmaceuticals Announces Nature Medicine Publication for Role of RTP801 in Pulmonary Injury and Emphysema

Monday, May 17, 2010 General News
Email Print This Page Comment bookmark
Font : A-A+

Quark Pharmaceuticals, Inc.

Juliana Friedman

+972 89 30 5111

[email protected]

The Ruth Group (investors / media)

Sara Pellegrino / Jason Rando

(646) 536-7002 / 7025

[email protected]

[email protected]



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook